EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:78741 - oxidopamine
| Formula | C8H11NO3 |
| Net Charge | 0 |
| Average Mass | 169.180 |
| Monoisotopic Mass | 169.07389 |
| SMILES | NCCc1cc(O)c(O)cc1O |
| InChI | InChI=1S/C8H11NO3/c9-2-1-5-3-7(11)8(12)4-6(5)10/h3-4,10-12H,1-2,9H2 |
| InChIKey | DIVDFFZHCJEHGG-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | human metabolite Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). neurotoxin A poison that interferes with the functions of the nervous system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| oxidopamine (CHEBI:78741) has functional parent dopamine (CHEBI:18243) |
| oxidopamine (CHEBI:78741) has role drug metabolite (CHEBI:49103) |
| oxidopamine (CHEBI:78741) has role human metabolite (CHEBI:77746) |
| oxidopamine (CHEBI:78741) has role neurotoxin (CHEBI:50910) |
| oxidopamine (CHEBI:78741) is a benzenetriol (CHEBI:22707) |
| oxidopamine (CHEBI:78741) is a catecholamine (CHEBI:33567) |
| oxidopamine (CHEBI:78741) is a primary amino compound (CHEBI:50994) |
| IUPAC Name |
|---|
| 5-(2-aminoethyl)benzene-1,2,4-triol |
| INNs | Source |
|---|---|
| oxidopamina | ChemIDplus |
| oxidopamine | WHO MedNet |
| oxidopamine | ChemIDplus |
| oxidopaminum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2,4,5-trihydroxyphenethylamine | ChemIDplus |
| 6-OHDA | ChemIDplus |
| 6-hydroxydopamine | ChemIDplus |
| hydroxydopamine | MetaCyc |
| topamine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Oxidopamine | Wikipedia |
| D05294 | KEGG DRUG |
| CPD-7666 | MetaCyc |
| HMDB0001537 | HMDB |
| LSM-37081 | LINCS |
| Registry Numbers | Sources |
|---|---|
| Reaxys:2211011 | Reaxys |
| Citations |
|---|